Results for tag: "MMR Vaccine"

The MMR Vaccine is a vaccine used to protect against measles, mumps, and rubella. It is typically administered in two doses, with the first dose given to children between 12 and 15 months of age, and the second dose given between 4 and 6 years of age. The MMR Vaccine is a live attenuated vaccine, meaning that it contains weakened versions of the viruses it is designed to protect against. The MMR Vaccine market is a subset of the larger Vaccines market, which is estimated to be worth billions of dollars. The MMR Vaccine market is driven by the need to protect against the three diseases it is designed to prevent, as well as the increasing demand for vaccines in general. The market is expected to grow in the coming years, as more countries adopt vaccination programs and the demand for vaccines increases. Some of the major companies in the MMR Vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and AstraZeneca. Show Less Read more